Shigatoxin 1 Activators
Shiga toxin 1 activators include a diverse array of chemical compounds that indirectly enhance the toxin's functional activity by manipulating various intracellular trafficking and stress pathways. Guanabenz and Tunicamycin, for example, interfere with the cell's stress responses and glycosylation processes respectively, which can inadvertently increase Shiga toxin 1 stability and presence in the cytosol, circumventing its normal degradation. Similarly, the disruption of endosomal acidification through Chloroquine or the alteration in cholesterol transport by U18666A can augment the toxin's intracellular delivery and endosomal escape. Shiga toxin 1 activators include a diverse array of chemical compounds that indirectly enhance the toxin's functional activity by manipulating various intracellular trafficking and stress pathways. Guanabenz and Tunicamycin, for example, interfere with the cell's stress responses and glycosylation processes respectively, which can inadvertently increase Shiga toxin 1 stability and presence in the cytosol, circumventing its normal degradation.
Compounds like Brefeldin A and Retro-2 cycl directly impair specific transport mechanisms within the Golgi and endosomes, leading to increased cytosolic accumulation of Shiga toxin 1. Shiga toxin 1 Activators encompass a range of chemical compounds that, through their distinct modes of action, can enhance the functional activity of Shiga toxin 1. For instance, Brefeldin A and Monensin, by disrupting Golgi and endosomal functions respectively, could lead to the impairment of intracellular trafficking and degradation of the toxin, thus increasing its cytosolic concentration. Similarly, Swainsonine and Castanospermine impede the proper folding of glycoproteins that are crucial for the cellular trafficking of Shiga toxin 1, suggesting an indirect enhancement of the toxin's stability and activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Guanabenz, an alpha-2 adrenergic agonist, can suppress endoplasmic reticulum (ER) stress responses. This suppression can lead to the enhanced activity of toxins like Shiga toxin 1 by facilitating their retrograde trafficking from the ER to the cytosol, bypassing degradation pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, which can enhance the activity of Shiga toxin 1 by affecting its intracellular transport and processing, indirectly leading to a higher cytosolic concentration of the toxin. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A, a cholesterol transport inhibitor, can interfere with endosome-lysosome trafficking. This may increase the efficiency of Shiga toxin 1's intracellular delivery to its target site by preventing its lysosomal degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises endosomal pH, which can potentiate Shiga toxin 1 by preventing its inactivation in acidic intracellular compartments, thus enhancing its endosomal escape into the cytoplasm. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine inhibits glucosidases, which can enhance Shiga toxin 1 activity by impairing the glycan processing required for its degradation, increasing the bioavailability of the toxin in cells. | ||||||
Exo2 | 304684-77-3 | sc-215011 sc-215011A | 5 mg 25 mg | $89.00 $288.00 | 1 | |
Exo2 disrupts the exocyst complex, potentially increasing Shiga toxin 1 activity by altering vesicular trafficking, enhancing the toxin's ability to reach its cytosolic target. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
Eeyarestatin I, an ER-associated degradation inhibitor, can enhance Shiga toxin 1 activity by blocking the degradation pathway of misfolded proteins, which may include preventing the degradation of the toxin. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a SERCA pump inhibitor, can enhance Shiga toxin 1 activity by disrupting calcium homeostasis, which may indirectly facilitate the toxin's transport to its cytosolic target. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which can enhance Shiga toxin 1 activity by disrupting normal vesicular trafficking and glycoprotein processing, potentially increasing the toxin's stability and cytosolic entry. | ||||||
NNC 711 | 145645-62-1 | sc-204132 sc-204132A | 5 mg 25 mg | $120.00 $313.00 | ||
NO-711, a GABA transporter inhibitor, can increase GABA levels, which might indirectly enhance Shiga toxin 1 activity by altering cellular signaling pathways that affect vesicular trafficking. | ||||||